EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS

The objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis patients with multiple drug resistance Subjects and methods. The chemotherapy efficiency was studied in 70 tuberculosis patients with extensive (XDR) or multiple (MDR) drug resistance who were treate...

Full description

Bibliographic Details
Main Authors: A. M. Tikhonov, M. V. Burаkovа, E. V. Vаniev, V. V. Romаnov, I. A. Vаsilyevа
Format: Article
Language:Russian
Published: New Terra Publishing House 2018-03-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1091
_version_ 1797696664347082752
author A. M. Tikhonov
M. V. Burаkovа
E. V. Vаniev
V. V. Romаnov
I. A. Vаsilyevа
author_facet A. M. Tikhonov
M. V. Burаkovа
E. V. Vаniev
V. V. Romаnov
I. A. Vаsilyevа
author_sort A. M. Tikhonov
collection DOAJ
description The objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis patients with multiple drug resistance Subjects and methods. The chemotherapy efficiency was studied in 70 tuberculosis patients with extensive (XDR) or multiple (MDR) drug resistance who were treated in clinics of Central Tuberculosis Research Institute All patients were divided into 3 groups: Group 1 (10 persons) included MDR TB patients, Group 2 (32 persons) included pre-XDR TB patients, Group 3 (28 persons) included XDR TB patientsResults of the study. High treatment efficiency in this difficult category of pulmonary tuberculosis patients with MDR and XDR was achieved when bedaquiline was added to the chemotherapy regimen Upon the completion of the main treatment course with bedaquiline, in the group of patients with MDR and pre-XDR the sputum conversion was achieved in 100%, and in XDR tuberculosis patients the sputum conversion rate made 893% The long-term treatment course with bedaquiline promoted the fastest sputum conversion, healing of cavities in the lungs of patients with disseminated tuberculosis and XDR, and it was not associated with a higher frequency of adverse events
first_indexed 2024-03-12T03:29:38Z
format Article
id doaj.art-2abaae790cd44ea186657064c3af0ca1
institution Directory Open Access Journal
issn 2075-1230
2542-1506
language Russian
last_indexed 2024-03-12T03:29:38Z
publishDate 2018-03-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj.art-2abaae790cd44ea186657064c3af0ca12023-09-03T13:29:15ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062018-03-01962222610.21292/2075-1230-2018-96-2-22-261091EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTSA. M. Tikhonov0M. V. Burаkovа1E. V. Vаniev2V. V. Romаnov3I. A. Vаsilyevа4ФГБНУ «Центральный научно-исследовательский институт туберкулеза», МоскваФГБНУ «Центральный научно-исследовательский институт туберкулеза», Москва; ФГАОУ ВО «Российский университет дружбы народов», МоскваФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний», МоскваФГБНУ «Центральный научно-исследовательский институт туберкулеза», МоскваФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний», МоскваThe objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis patients with multiple drug resistance Subjects and methods. The chemotherapy efficiency was studied in 70 tuberculosis patients with extensive (XDR) or multiple (MDR) drug resistance who were treated in clinics of Central Tuberculosis Research Institute All patients were divided into 3 groups: Group 1 (10 persons) included MDR TB patients, Group 2 (32 persons) included pre-XDR TB patients, Group 3 (28 persons) included XDR TB patientsResults of the study. High treatment efficiency in this difficult category of pulmonary tuberculosis patients with MDR and XDR was achieved when bedaquiline was added to the chemotherapy regimen Upon the completion of the main treatment course with bedaquiline, in the group of patients with MDR and pre-XDR the sputum conversion was achieved in 100%, and in XDR tuberculosis patients the sputum conversion rate made 893% The long-term treatment course with bedaquiline promoted the fastest sputum conversion, healing of cavities in the lungs of patients with disseminated tuberculosis and XDR, and it was not associated with a higher frequency of adverse eventshttps://www.tibl-journal.com/jour/article/view/1091туберкулез легкихлекарственная устойчивость микобактерий туберкулезаэффективность химиотерапии
spellingShingle A. M. Tikhonov
M. V. Burаkovа
E. V. Vаniev
V. V. Romаnov
I. A. Vаsilyevа
EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
Туберкулез и болезни лёгких
туберкулез легких
лекарственная устойчивость микобактерий туберкулеза
эффективность химиотерапии
title EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
title_full EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
title_fullStr EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
title_full_unstemmed EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
title_short EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
title_sort efficiency of chemotherapy with bedaquiline in drug resistant pulmonary tuberculosis patients
topic туберкулез легких
лекарственная устойчивость микобактерий туберкулеза
эффективность химиотерапии
url https://www.tibl-journal.com/jour/article/view/1091
work_keys_str_mv AT amtikhonov efficiencyofchemotherapywithbedaquilineindrugresistantpulmonarytuberculosispatients
AT mvburakova efficiencyofchemotherapywithbedaquilineindrugresistantpulmonarytuberculosispatients
AT evvaniev efficiencyofchemotherapywithbedaquilineindrugresistantpulmonarytuberculosispatients
AT vvromanov efficiencyofchemotherapywithbedaquilineindrugresistantpulmonarytuberculosispatients
AT iavasilyeva efficiencyofchemotherapywithbedaquilineindrugresistantpulmonarytuberculosispatients